PDF(Pubmed)
Abstract：
BACKGROUND: Robotic-assisted gait training (RAGT) devices are effective for children with cerebral palsy (CP). Many RAGT devices have been created and put into clinical rehabilitation treatment. Therefore, we aimed to investigate the safety and feasibility of a new RAGT for children with CP.
METHODS: This study is a cross-over design with 23 subjects randomly divided into two groups. The occurrence of adverse events and changes in heart rate and blood pressure were recorded during each AiWalker-K training. Additionally, Gross Motor Function Measure-88 (GMFM-88), Pediatric Balance Scale (PBS), 6 Minutes Walking Test (6MWT), Physiological Cost Index, and Edinburgh Visual Gait Score (EVGS) were used to assess treatment, period, carry-over, and follow-up effects in this study.
RESULTS: Adverse events included joint pain, skin pain, and injury. Heart rate and blood pressure were higher with the AiWalker-K compared to the rest (P < 0.05), but remained within safe ranges. After combined treatment with AiWalker-K and routine rehabilitation treatment, significant improvements in 6MWT, GMFM-88 D and E, PBS, and EVGS were observed compared to routine rehabilitation treatment alone (P < 0.05).
CONCLUSIONS: Under the guidance of experienced medical personnel, AiWalker-K can be used for rehabilitation in children with CP.
METHODS: This study is a cross-over design with 23 subjects randomly divided into two groups. The occurrence of adverse events and changes in heart rate and blood pressure were recorded during each AiWalker-K training. Additionally, Gross Motor Function Measure-88 (GMFM-88), Pediatric Balance Scale (PBS), 6 Minutes Walking Test (6MWT), Physiological Cost Index, and Edinburgh Visual Gait Score (EVGS) were used to assess treatment, period, carry-over, and follow-up effects in this study.
RESULTS: Adverse events included joint pain, skin pain, and injury. Heart rate and blood pressure were higher with the AiWalker-K compared to the rest (P < 0.05), but remained within safe ranges. After combined treatment with AiWalker-K and routine rehabilitation treatment, significant improvements in 6MWT, GMFM-88 D and E, PBS, and EVGS were observed compared to routine rehabilitation treatment alone (P < 0.05).
CONCLUSIONS: Under the guidance of experienced medical personnel, AiWalker-K can be used for rehabilitation in children with CP.
摘要：
背景：机器人辅助步态训练（RAGT）装置对脑瘫（CP）儿童有效。已经创建了许多RAGT设备并将其用于临床康复治疗。因此,我们的目的是探讨新型RAGT用于CP患儿的安全性和可行性.
方法：本研究是一项交叉设计，将23名受试者随机分为两组。在每次AiWalker-K训练期间记录不良事件的发生以及心率和血压的变化。此外,粗大运动功能测量-88(GMFM-88),儿科平衡量表（PBS），6分钟步行测试（6MWT），生理成本指数，和爱丁堡视觉步态评分（EVGS）用于评估治疗，period,结转,以及本研究的后续效果。
结果：不良事件包括关节痛，皮肤疼痛,和伤害。AiWalker-K组的心率和血压高于其他组(P<0.05),但仍在安全范围内。AiWalker-K联合常规康复治疗后,6MWT的显著改进，GMFM-88D和E，PBS,与单纯常规康复治疗相比，EVGS观察（P<0.05）。
结论：在经验丰富的医务人员的指导下，AiWalker-K可用于CP患儿的康复治疗。
方法：本研究是一项交叉设计，将23名受试者随机分为两组。在每次AiWalker-K训练期间记录不良事件的发生以及心率和血压的变化。此外,粗大运动功能测量-88(GMFM-88),儿科平衡量表（PBS），6分钟步行测试（6MWT），生理成本指数，和爱丁堡视觉步态评分（EVGS）用于评估治疗，period,结转,以及本研究的后续效果。
结果：不良事件包括关节痛，皮肤疼痛,和伤害。AiWalker-K组的心率和血压高于其他组(P<0.05),但仍在安全范围内。AiWalker-K联合常规康复治疗后,6MWT的显著改进，GMFM-88D和E，PBS,与单纯常规康复治疗相比，EVGS观察（P<0.05）。
结论：在经验丰富的医务人员的指导下，AiWalker-K可用于CP患儿的康复治疗。
